What was supposed to be a five-year, $750,000 NIH grant to fund Dr. Charity Oyedeji's sickle cell research at Duke University ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

Extreme pain, known as a pain crisis, is one of the hallmark symptoms of SCD. With frequent hospitalizations, chronic pain ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding cut, justified by NIH as a move against diversity, equity, and inclusion ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.

With gene therapy in the works, clinical trials for sickle cell disease still lack Black American participants.

The World Health Organization has released its first-ever global guideline on the management of sickle cell disease during ...

Nicole and Kyle Law have a strong bond. “She’s always there for me whenever I need her. Being sick and being healthy, too.

Sickle cell anaemia test prices in India have significantly dropped to under Rs 50, facilitating widespread diagnosis. The ...